Search

Author/Creator Muro, K

11. 684PAn exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for peritoneal disseminated gastric cancer patients with inadequate oral intake. (23rd October 2018)

Authors:
Kadowaki, S; Ishigami, H; Muro, K; Yoshida, S; Hirono, Y; Tomita, T; Yabusaki, H; Kusumoto, T; Ota, M; Kodera, Y; Tsuji, Y; Hidemura, A; Hachiya, O; Oba, K; Kitayama, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study. (18th October 2018)

Authors:
Yoshino, T; Portnoy, D C; Obermannová, R; Bodoky, G; Prausová, J; Garcia-Carbonero, R; Ciuleanu, T; García-Alfonso, P; Cohn, A L; Van Cutsem, E; Yamazaki, K; Lonardi, S; Muro, K; Kim, T W; Yamaguchi, K; Grothey, A; O'Connor, J; Taieb, J; Wijayawardana, S R; Hozak, R R
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. (24th June 2018)

Authors:
Shitara, K; Özgüroğlu, M; Bang, Y J; Di Bartolomeo, M; Mandalà, M; Ryu, M H; Fornaro, L; Olesiński, T; Caglevic, C; Chung, H; Muro, K; Gökkurt, E; Mansoor, W; McDermott, R; Schacham-Shmueli, E; Chen, X; Kang, S P; Mayo, C; Ohtsu, A; Fuchs, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. (2nd July 2019)

Authors:
Metges, J; François, E; Shah, M; Adenis, A; Enzinger, P; Kojima, T; Muro, K; Bennouna, J; Hsu, C; Moriwaki, T; Kim, S; Lee, S; Kato, K; Shen, L; Qin, S; Ferreira, P; Wang, R; Bhagia, P; Kang, S; Doi, T
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. P-034PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer. (2nd July 2019)

Authors:
Muro, K; Uetake, H; Tsuchihara, K; Shitara, K; Yamazaki, K; Ota, M; Oki, E; Sato, T; Naitoh, T; Komatsu, Y; Kato, T; Yamanaka, K; Mori, I; Soeda, J; Hihara, M; Yamanaka, T; Akagi, K; Ochiai, A; Yoshino, T
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. (20th June 2018)

Authors:
Kato, T; Satake, H; Oba, K; Kagawa, Y; Yasui, H; Nakamura, M; Watanabe, T; Matsumoto, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Sakamoto, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. (20th June 2018)

Authors:
Kato, T; Satake, H; Oba, K; Kagawa, Y; Yasui, H; Nakamura, M; Watanabe, T; Matsumoto, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Sakamoto, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Van Cutsem, E; Narita, Y; Pentheroudakis, G; Baba, E; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Kato, K; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Nakajima, T E; Shitara, K; Kawakami, H; Tsushima, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Lordick, F; Tsushima, T; Pentheroudakis, G; Baba, E; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Kato, K; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Nakajima, T E; Shitara, K; Kawakami, H; Narita, Y
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗